SEP-363856

• CAT Number: I015498
• CAS Number: 1310426-33-5
• Molecular Formula: C₉H₁₃NOS
• Molecular Weight: 183.27
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: 1-[(7S)-5,7-dihydro-4H-thieno[2,3-c]pyran-7-yl]-N-methylmethanamine
• InChI: InChI=1S/C9H13NOS/c1-10-6-8-9-7(2-4-11-8)3-5-12-9/h3,5,8,10H,2,4,6H2,1H3/t8-/m0/s1
• InChIKey: ABDDQTDRAHXHOC-QMMMGPOBSA-N
• SMILES: CNC[C@H]1C2=C(CCO1)C=CS2

SEP-363856 (CAT: I015498) is an innovative psychotropic agent with a unique mechanism of action distinct from traditional antipsychotics, as it does not directly target dopamine D2 or serotonin 5-HT2A receptors. Instead, its effects are mediated through TAAR1 (trace amine-associated receptor 1) agonism and 5-HT1A receptor partial agonism. This novel pharmacological profile contributes to its antipsychotic-like effects, making it a promising candidate for the treatment of schizophrenia and other neuropsychiatric disorders. SEP-363856 offers a differentiated approach with potential advantages in efficacy and tolerability compared to conventional antipsychotics, making it a valuable tool for advancing research in neuropsychopharmacology and drug development.